No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs12137426 |
chr1:226458998-226458999 |
Weak transcription Strong transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
2 |
rs374194494 |
chr1:226459024-226459025 |
Weak transcription Strong transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs116777449 |
chr1:226459036-226459037 |
Weak transcription Strong transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs545612421 |
chr1:226459037-226459038 |
Weak transcription Strong transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs561626263 |
chr1:226459056-226459057 |
Weak transcription Strong transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs187875564 |
chr1:226459080-226459081 |
Weak transcription Strong transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs377140499 |
chr1:226459229-226459230 |
Weak transcription Strong transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs193092382 |
chr1:226459243-226459244 |
Weak transcription Strong transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs576838629 |
chr1:226459251-226459252 |
Weak transcription Strong transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs544114733 |
chr1:226459253-226459254 |
Weak transcription Strong transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs565546221 |
chr1:226459267-226459268 |
Weak transcription Strong transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs377625845 |
chr1:226459380-226459381 |
Weak transcription Strong transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs532777490 |
chr1:226459398-226459399 |
Weak transcription Strong transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs541566180 |
chr1:226459433-226459434 |
Weak transcription Strong transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs144031394 |
chr1:226459493-226459494 |
Weak transcription Strong transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs10799344 |
chr1:226459577-226459578 |
Weak transcription Strong transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
17 |
rs201435257 |
chr1:226459596-226459597 |
Weak transcription Strong transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs146430128 |
chr1:226459627-226459628 |
Weak transcription Strong transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs530402949 |
chr1:226459686-226459687 |
Weak transcription Strong transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs548076606 |
chr1:226459692-226459693 |
Weak transcription Strong transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs35313284 |
chr1:226459722-226459723 |
Weak transcription Strong transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs397774210 |
chr1:226459729-226459730 |
Weak transcription Strong transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs397813166 |
chr1:226459730-226459731 |
Weak transcription Strong transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs201408490 |
chr1:226459731-226459732 |
Weak transcription Strong transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs202000408 |
chr1:226459733-226459734 |
Weak transcription Strong transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs200064657 |
chr1:226459749-226459750 |
Weak transcription Strong transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs112983670 |
chr1:226459781-226459782 |
Weak transcription Strong transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs185844477 |
chr1:226459881-226459882 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs189931614 |
chr1:226459945-226459946 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs192276101 |
chr1:226459963-226459964 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs570367203 |
chr1:226459966-226459967 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs534515585 |
chr1:226460001-226460002 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs546762616 |
chr1:226460048-226460049 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs566085827 |
chr1:226460082-226460083 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs570128823 |
chr1:226460083-226460084 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs75580231 |
chr1:226460097-226460098 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs76680840 |
chr1:226460099-226460100 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs112433000 |
chr1:226460100-226460101 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs184621650 |
chr1:226460137-226460138 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs188553930 |
chr1:226460159-226460160 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs112005690 |
chr1:226460166-226460167 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs559299988 |
chr1:226460184-226460185 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs7552015 |
chr1:226460188-226460189 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
44 |
rs541305562 |
chr1:226460202-226460203 |
Weak transcription Enhancers Strong transcription Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs555346267 |
chr1:226460241-226460242 |
Weak transcription Enhancers Strong transcription Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs76033931 |
chr1:226460260-226460261 |
Weak transcription Enhancers Strong transcription Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs116126092 |
chr1:226460285-226460286 |
Weak transcription Enhancers Strong transcription Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs574477874 |
chr1:226460289-226460290 |
Weak transcription Enhancers Strong transcription Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs143143591 |
chr1:226460305-226460306 |
Weak transcription Enhancers Strong transcription Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs566099854 |
chr1:226460320-226460321 |
Weak transcription Enhancers Strong transcription Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|